Pharmaceutical Benefits Scheme restrictions on anti‐epileptic drug prescribing promote unsafe and outdated practice
Sign Up to like & getrecommendations! Published in 2019 at "Medical Journal of Australia"
DOI: 10.5694/mja2.50246
Abstract: In May 2018, the European Medicines Agency banned the prescription of valproate to women of childbearing age for use in migraine and bipolar disorder unless they are enrolled in a special pregnancy prevention program. Its… read more here.
Keywords: risk; anti epileptic; pharmaceutical benefits; practice ... See more keywords